The global dental consumables market size is calculated at USD 39.48 billion in 2025 and is forecasted to reach around USD 79.18 billion by 2034, accelerating at a CAGR of 8.04% from 2025 to 2034. The North America market size surpassed USD 17.51 billion in 2024 and is expanding at a CAGR of 8.05% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Material Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dental Consumables Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dental Consumables Market, by Product Type
8.1.1. Dental Implants
8.1.1.1. Market Revenue and Forecast
8.1.2. Dental Prosthetics
8.1.2.1. Market Revenue and Forecast
8.1.3. Endodontics
8.1.3.1. Market Revenue and Forecast
8.1.4. Orthodontics
8.1.4.1. Market Revenue and Forecast
8.1.5. Periodontics
8.1.5.1. Market Revenue and Forecast
8.1.6. Retail Dental Care Essentials
8.1.6.1. Market Revenue and Forecast
8.1.7. Others
8.1.7.1. Market Revenue and Forecast
9.1. Dental Consumables Market, by End User
9.1.1. Dental Hospitals and Clinic
9.1.1.1. Market Revenue and Forecast
9.1.2. Dental Laboratory
9.1.2.1. Market Revenue and Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Forecast
10.1. Dental Consumables Market, by Material
10.1.1. Metals
10.1.1.1. Market Revenue and Forecast
10.1.2. Polymers
10.1.2.1. Market Revenue and Forecast
10.1.3. Ceramics
10.1.3.1. Market Revenue and Forecast
10.1.4. Biomaterials
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by End User
11.1.3. Market Revenue and Forecast, by Material
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by End User
11.1.4.3. Market Revenue and Forecast, by Material
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by End User
11.1.5.3. Market Revenue and Forecast, by Material
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by End User
11.2.3. Market Revenue and Forecast, by Material
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by End User
11.2.4.3. Market Revenue and Forecast, by Material
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by End User
11.2.5.3. Market Revenue and Forecast, by Material
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by End User
11.2.6.3. Market Revenue and Forecast, by Material
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by End User
11.2.7.3. Market Revenue and Forecast, by Material
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by End User
11.3.3. Market Revenue and Forecast, by Material
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by End User
11.3.4.3. Market Revenue and Forecast, by Material
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by End User
11.3.5.3. Market Revenue and Forecast, by Material
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by End User
11.3.6.3. Market Revenue and Forecast, by Material
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by End User
11.3.7.3. Market Revenue and Forecast, by Material
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by End User
11.4.3. Market Revenue and Forecast, by Material
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by End User
11.4.4.3. Market Revenue and Forecast, by Material
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by End User
11.4.5.3. Market Revenue and Forecast, by Material
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by End User
11.4.6.3. Market Revenue and Forecast, by Material
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by End User
11.4.7.3. Market Revenue and Forecast, by Material
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by End User
11.5.3. Market Revenue and Forecast, by Material
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product
11.5.4.2. Market Revenue and Forecast, by End User
11.5.4.3. Market Revenue and Forecast, by Material
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by End User
11.5.5.3. Market Revenue and Forecast, by Material
12.1. Myriad Genetics Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Guardant Health Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Exact Sciences Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bio-Rad Laboratories Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Agena Bioscience Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Personal Genome Diagnostics Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Exosome Diagnostics Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. ANGLE Plc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. F. Hoffmann-La Roche Ltd.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Myriad Genetics Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at [email protected]
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample